Cvs Pharmacy #00952 Medicare Supplier Location: 205 South Broadway, Lawerence, Massachusetts 01843 Phone: (978) 681-9943 |
News Archive
Researchers have found a possible way to protect people with multiple sclerosis (MS) from severe long-term disability: increase nervous-system levels of a vital compound, called nicotinamide adenine dinucleotide (NAD), by giving its chemical precursor - nicotinamide, a form of vitamin B3.
A new study led by Belgian and Spanish researchers published in Scientific Reports adds evidence about the potential benefits of green tea extracts in Down syndrome.
Forest Laboratories have announced that Combunox (Oxycodone HCl and Ibuprofen) Tablets (CII), the first and only fixed-dose combination of the opioid oxycodone HCl (5 mg) and the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen (400 mg), was approved by the U.S. Food and Drug Administration (FDA) for the short-term management of acute, moderate to severe pain.
OncoGenex Pharmaceuticals, Inc. announced today that its Phase 3 ENSPIRIT trial evaluating custirsen in the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) is continuing as planned per the recommendation of an Independent Data Monitoring Committee (IDMC). This decision was based upon completion of the second and final planned interim futility analysis.
Family Research Council praised today's decision by the federal Advisory Committee on Blood Safety and Availability to reject any change in current blood donation rules. Current policy provides that men who have had sex with men at any time since 1977 are permanently "deferred" from acting as blood donors, because of the high rates of HIV infection in that population. The panel, which offers non-binding advice to the federal Department of Health and Human Services, voted 9-6 on Friday afternoon against recommending any immediate change in the policy.
› Verified 4 days ago